Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of GENOSS® DES (Sirolimus-eluting Coronary Stent System) in Patients With Multivessel Coronary Artery Disease (MVCAD): A Multicenter, Prospective, Observational Study

NCT06168305 is registered in ClinicalTrials.gov with Genoss Co., Ltd. as lead sponsor.

NCT NCT06168305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06168305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of GENOSS® DES (Sirolimus-eluting Coronary Stent System) in Patients With Multivessel Coronary Artery Disease (MVCAD): A Multicenter, Prospective, Observational Study
Lead sponsor
Genoss Co., Ltd.
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 15, 2023
Completion date
February 28, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multivessel coronary artery disease, percutaneous coronary intervention